Quotient and Transmedic sign distribution agreement in Southeast Asia
Quotient and Transmedic sign distribution agreement in Southeast Asia
Quotient and Transmedic have signed a distribution agreement, which will enable Transmedic to distribute Alba by Quotient® and MosaiQ™ in five countries in Southeast Asia.This significant partnership reaffirms Quotient’s commitment to grow and expand its geographical presence. It will enable both parties to introduce new quality services to the healthcare industry in Southeast Asia and enhance patient care.With a history spanning over four decades, Transmedic is a leader in medical technology. Headquartered in Singapore, the company operates in Southeast Asia. It is active in the distribution of medical devices and specialized drugs, education, and post-sales support.The distribution agreement takes effect immediately and will cover the following five countries in Southeast Asia:
Indonesia
Malaysia
Singapore
Thailand
Vietnam
Transmedic will be able to distribute the Alba by Quotient portfolio, our range of high-quality reagents, along with the MosaiQ solution, which is currently under development and aims to facilitate fast and accurate test results in the autoimmune diseases and allergy fields.“We are thrilled to collaborate with such a strong partner and to be able to expand our operations in Southeast Asia,” said Khaled Hamed, Quotient’s Head of APAC.To find out more about Transmedic, please visit their website: www.transmedicgroup.com
Trending Topics
Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.
AliveDx Suisse S.A. and Disera Tibbi Malzeme Lojistik. san. Tic. A.S have signed a distribution agreement, which will enable Disera to distribute the MosaiQ® and LumiQ™ solutions in Türkiye. The distribution agreement takes effect immediately. This strategic partnership with an
AliveDx Suisse S.A. and Vital Care Prod SPA have signed a distribution agreement, which will enable Vital Care to distribute the MosaiQ® and LumiQ™ solutions in Algeria. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to broadening
Alba Bioscience Limited and Medline Industries, LP have signed a distribution agreement, which will enable Medline to distribute Alba’s range of reagents in the USA. The distribution agreement takes effect immediately. Alba develops and manufactures high-quality blood bank reagents for
Are you facing challenges in achieving accurate, timely diagnoses for patients with suspected autoimmune conditions? Join us for an exclusive webinar where Dr. Gerber Gomez, Scientific & Medical Officer at AliveDx, will share: Date: 13 March 2025 Time: 14h00-15h00 CET
We are excited to announce that our MosaiQ AiPlex® Celiac Disease (CD) solution has obtained Medical Device Authority (MDA) registration in Malaysia! The registration confirms the safety, quality, and effectiveness of our system. With this approval, AliveDx is now authorized
Alba Bioscience is pleased to have completed the UK National Health Service (NHS) Evergreen Sustainable Supplier Assessment. The Assessment is a self-assessment and reporting tool and resulted in Alba Bioscience receiving a Level 2: Comprehensive net zero targets and reporting
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.